KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence

Pancreatic ductal adenocarcinoma (PDAC) patients eligible for curative surgery undergo unpredictable disease relapse. Even patients with a good pathological response after neoadjuvant treatment (NAT) remain susceptible to recurrent PDAC. Molecular analysis of R0 margins may identify patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Amintas, Samuel, Fernandez, Benjamin, Chauvet, Alexandre, Chiche, Laurence, Laurent, Christophe, Belleannée, Geneviève, Marty, Marion, Buscail, Etienne, Dabernat, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864048/
https://www.ncbi.nlm.nih.gov/pubmed/35194118
http://dx.doi.org/10.1038/s41598-022-07004-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864048/
https://www.ncbi.nlm.nih.gov/pubmed/35194118
http://dx.doi.org/10.1038/s41598-022-07004-x

Ejemplares similares